In other words, cinnamic acid does not act on the majority of liver cancer-associated targets, but rather on those more directly involved in critical pathways (e.g., PI3K/AKT), as subsequently supported by topological and enrichment analyses. The gene discussed is AKT1; the disease is liver cancer.